Jump to content

Diamyd Medical

From Wikipedia, the free encyclopedia

Diamyd Medical AB (Stockholm NASDAQ, First North) is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.

Diamyd Medical logo

The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå.[1]

[edit]


References

[edit]
  1. ^ "Annual Report 2021/2022" (PDF). Diamyd Medical AB. Retrieved 20 February 2023.